Skip to main navigation Skip to search Skip to main content

A Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Final Analysis of Second Dose Expansion

  • Jesus G. Berdeja
  • , Tara B. Gregory
  • , Edward Faber
  • , Jeffrey Matous
  • , Lowell Hart
  • , Joseph R. Mace
  • , Edward R. Arrowsmith
  • , Ian W. Flinn
  • Sarah Cannon Research Institute
  • Oncology Hematology Care, Inc., Cincinnati, OH

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume128
Issue number22
DOIs
StatePublished - Dec 2 2016
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Surgery
  • Internal Medicine

Cite this